Please assess the completion status of the following clinical trial:

Trial Title: Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosed with complicated skin and skin structure infection with at least 2 signs and symptoms~* Suspected or confirmed infection due to a gram-positive organism~Exclusion Criteria:~* Complicated skin and skin structure infection due to gram-negative organisms~* Complicated skin and skin structure infections requiring more than 7 days of therapy~* Uncontrolled diabetes~* Chronic systemic immunosuppressive therapy~* AIDS with CD4 count \< 200 cells/mm3~* Uncontrolled hypertension~* Mild moderate or severe renal failure~* Severe hepatic disease~* Neutropenia~* Use of antidepressants such as SSRIs or MAOIs for 14 days before first dose of study drug~* Women who are pregnant or nursing

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- TR-701 200 mg (Type: EXPERIMENTAL): None
- TR-701 300 mg (Type: EXPERIMENTAL): None
- TR-701 400 mg (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).